32 studies found for:    " June 22, 2011":" July 22, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 22, 2011":" July 22, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: Dolutegravir 50 mg tablet;   Drug: Dolutegravir 50 mg oral granules
2 Completed Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe
Condition: HIV Infection
Intervention:
3 Completed Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
Condition: HIV Prevention
Interventions: Drug: Tenofovir gel;   Drug: Universal placebo gel
4 Completed
Has Results
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir(DRV);   Drug: Ritonavir;   Drug: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
5 Completed Treating South African Pregnant Women for Methamphetamine
Conditions: HIV;   Drug Addiction
Interventions: Behavioral: Psycho-education;   Behavioral: Experimental
6 Recruiting Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
7 Recruiting Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM
Conditions: HIV;   Sexually Transmitted Infections
Interventions: Behavioral: Connect 'n Unite;   Behavioral: Wellness Promotion
8 Completed Genetics and HIV-1 Protease Inhibitors
Condition: HIV
Intervention: Drug: Atazanavir
9 Completed A Parenting and Self-Care Intervention for HIV Infected Mothers
Condition: HIV
Intervention: Behavioral: IMAGE Intervention
10 Active, not recruiting The Role of Genital Warts in HIV Acquisition in Peru
Conditions: Anogenital Warts;   HIV
Intervention:
11 Recruiting Urban Health Study II
Condition: HIV
Interventions: Behavioral: Standard Referral;   Behavioral: Project Bridge
12 Withdrawn Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women
Condition: HIV Infected
Intervention: Drug: Tenofovir, Emtricitabine, Atazanavir, Ritonavir
13 Active, not recruiting HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068;   Drug: Raltegravir;   Drug: Tenofovir;   Drug: Ritonavir;   Drug: Atazanavir
14 Unknown  Stanford Universities: The Stanford HIV Aging Cohort
Condition: Acquired Immunodeficiency Syndrome
Intervention:
15 Completed HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth
Conditions: Acquired Immunodeficiency Syndrome;   Stress Disorders, Post-Traumatic
Intervention: Behavioral: Questionnaires
16 Unknown  Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
Conditions: Influenza, Human;   Human Immunodeficiency Virus I Infection
Intervention:
17 Completed Immune Responses to Two Experimental HIV Vaccines in Healthy Adults
Conditions: HIV Negative;   Adaptive Immunity;   Innate Immunity
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP
18 Completed
Has Results
Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use
Condition: HIV-1 Patients
Intervention:
19 Unknown  GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance
Conditions: HIV-1 Infected Patients;   Fold-change Resistance;   Resistance Mutations
Intervention:
20 Completed Increasing Viral Testing in the Emergency Department
Conditions: Drug Use;   HIV;   Hepatitis C
Intervention: Behavioral: Brief motivational intervention

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years